Mirum Pharmaceuticals (MIRM) PT Lowered to $137 at Citizens
Tweet
Share
E-mailGet Alerts MIRM Hot Sheet
Price: $100.90 +0.27%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 0
Join SI Premium – FREE
Citizens analyst Jonathan Wolleben lowered the price target on Mirum Pharmaceuticals (NASDAQ: MIRM) to $137.00 (from $146.00) while maintaining a Market Outperform rating.
You May Also Be Interested In
- Jefferies Downgrades Xior Student Housing NV (XIOR:BB) to Hold
- Kawasaki Kisen Kaisha Ltd. (9107:JP) (KAIKY) PT Raised to JPY3,300 at Nomura/Instinet
- Nippon Yusen Kabushiki Kaisha (9101:JP) (NPNYY) PT Raised to JPY8,800 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
